Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)

Table 2 Factors associated with HBV testing in HIV-infected patients using multilevel logistic regressions

	HBsAg tested		Univariate analysis			Multivariate analysis
	n	(%)	OR	95% CI	p	Adjusted OR	95% CI	p
Gender
Men	103	(23.2%)	1.00			1.00
Women	199	(15.7%)	0.59	0.43–0.79	< 0.001	0.64	0.46–0.89	0.010
School educational level
Lower than secondary	76	(12.8%)	1.00			1.00
Secondary or higher	226	(20.4%)	1.53	1.11–2.11	0.010	1.38	1.02–1.90	0.042
Living below poverty line^a
No	32	(25.4%)	1.00
Yes	270	(17.9%)	0.60	0.39–0.97	0.036
Use of razor blade or clipper of another person
Never	177	(16.5%)	1.00
Sometimes	122	(20.2%)	1.44	1.07–1.95	0.017
Time of ART initiation
Prior to 2010	101	(14.5%)	1.00			1.00
2010 or after	201	(19.9%)	1.45	1.12–1.88	0.005	1.66	1.23–2.27	< 0.001
ALT level (per 10 IU/L increase)			1.12	1.06–1.18	< 0.001	1.26	1.15–1.39	< 0.001

Abbreviations: ART antiretroviral therapy, CI confidence interval, OR odds ratio, ALT Alanine aminotransferase
^a Household monthly income < 28,310 Francs CFA, approximately 43 Euros
The following characteristics were not associated with HBV testing: age; residence setting; marital status; paid activity; household monthly income; number of meals per day; HIV clinical stage at ART initiation; CD4 cell count; HIV viral load; AST level; body mass index; hospitalization in the previous 3 months; consultation of a traditional healer in the previous 3 months; history of incarceration; scarification, tattoo or piercings; number of sexual partners during lifetime; beer consumption; journey time to arrive at study hospital; region, setting and administrative sector of study hospital; type of HIV service; task-shifting of ART prescription renewals or follow-up consultations to nurses

ISSN: 1471-2334